Bedel Financial Consulting’s Spero Therapeutics SPRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,837
Closed -$33K 789
2022
Q1
$33K Hold
3,837
0.01% 469
2021
Q4
$61K Hold
3,837
0.02% 361
2021
Q3
$71K Hold
3,837
0.02% 332
2021
Q2
$54K Buy
+3,837
New +$54K 0.02% 362